Cassiopea SpA

Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange

Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange

Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange

COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A ANNOUNCE SETTLEMENT OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES IN CASSIOPEA S.P.A.

COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE FINAL RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A.

COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PUBLIC EXCHANGE OFFER FOR all publicly held shares of CASSIOPEA S.P.A.

COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. AND DECLARE THE OFFER SUCCESSFUL

COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH PROVISIONAL INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A.

Cassiopea SpA announces the US launch of Winlevi® (clascoterone cream 1%)

COSMO PHARMACEUTICALS N.V. LAUNCHES PUBLIC EXCHANGE OFFER TO ACQUIRE CASSIOPEA S.P.A.

Cassiopea SpA Announces Topline Results of Phase II Proof of Concept Trial of Clascoterone Solution for the Treatment of Androgenetic Alopecia in Females

Cassiopea SpA and Sun Pharma announce the expiry of the HSR Act process and the successful consummation of their Winlevi® (clascoterone cream 1%) agreement

Cassiopea Announces Results for First Half of 2021

Cassiopea SpA and Sun Pharma Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada

Cassiopea announces results of AGM 2021

Lists of candidates for the board of directors at the AGM 2021

Cassiopea Reports Year End 2020 Results